GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (MIL:1JNJ) » Definitions » Cash Flow for Lease Financing

Johnson & Johnson (MIL:1JNJ) Cash Flow for Lease Financing : €0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Johnson & Johnson Cash Flow for Lease Financing?

Johnson & Johnson's Cash Flow for Lease Financing for the three months ended in Dec. 2024 was €0 Mil. Johnson & Johnson's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was €0 Mil.

Compared with last quarter (€0 Mil in Sep. 2024 ), Johnson & Johnson's Cash Flow for Lease Financing remained the same in Dec. 2024 (€0 Mil).

Johnson & Johnson Cash Flow for Lease Financing Historical Data

The historical data trend for Johnson & Johnson's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cash Flow for Lease Financing Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Johnson & Johnson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Johnson & Johnson Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (MIL:1JNJ) » Definitions » Cash Flow for Lease Financing
Comparable Companies
ABBV MRK AMGN PFE GILD BMY BIIB OGN AMRN SCLX LLY OCSE:NOVO B XSWX:ROG LSE:AZN XSWX:NOVN XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276
Traded in Other Exchanges
JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan JNJd:UK 0R34:UK JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria JNJ:Argentina
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Website
https://www.jnj.com
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines